Agenus AGEN
NASDAQ AGEN
$8.28 +0.04 (+0.49%)
As of: Sep 4, 2026 · 2:33 PM EDT

Agenus (AGEN) Shares Outstanding (2010 - 2026)

Agenus (AGEN) posted quarterly Shares Outstanding (Entity) of $38.5 million for Q1 2026, up 45.02% year-over-year from $26.6 million in Q1 2025, and up 9.07% quarter-over-quarter from $35.3 million in Q4 2025.

Analysis

Agenus (AGEN) Shares Outstanding (2010 - 2026) Analysis & Trends

Agenus' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $38.5 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 45.02% year-over-year to $38.5 million; the TTM figure through Mar 2026 stood at $38.5 million (up 45.02% YoY), while the FY2025 annual figure was $35.3 million, up 49.44% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $38.5 million, up from $35.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $38.5 million in Q1 2026, with the low at $13337.0 in Q1 2022.
  • The 5-year median for Shares Outstanding (Entity) is $21.0 million (2024), against an average of $14.8 million.
  • The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) slumped 99.87% in 2022, then surged 132312.49% in 2024.
  • Agenus' Shares Outstanding (Entity) stood at $14087.0 in 2022, then advanced by 27.02% to $17894.0 in 2023, then soared by 131983.38% to $23.6 million in 2024, then surged by 49.44% to $35.3 million in 2025, then gained by 9.07% to $38.5 million in 2026.
  • Business Quant data shows AGEN's Shares Outstanding (Entity) at $38.5 million in Q1 2026, $35.3 million in Q4 2025, and $32.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 138.77 Bn 130.92 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.51 Bn 77.52 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn 61.30 Mn
4 Moderna 58.20 Bn 53.06 Bn 52.00 Mn 398.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - 210.89 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 111.58 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 133.61 Mn
8 Royalty Pharma 28.40 Bn 27.56 Bn - 445.06 Mn
9 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 217.35 Mn
10 Agenus 343.02 Mn 343.02 Mn 34.52 Mn 41.34 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.34 Mn
Mar 31, 2026 37.94 Mn
Dec 31, 2025 29.73 Mn
Sep 30, 2025 31.89 Mn
Jun 30, 2025 28.12 Mn
Mar 31, 2025 24.47 Mn
Dec 31, 2024 21.47 Mn
Sep 30, 2024 21.55 Mn
Jun 30, 2024 21.06 Mn
Mar 31, 2024 20.37 Mn
Dec 31, 2023 17.89 Mn
Sep 30, 2023 18.91 Mn
Jun 30, 2023 17.57 Mn
Mar 31, 2023 15.86 Mn
Dec 31, 2022 14.09 Mn
Sep 30, 2022 14.34 Mn
Jun 30, 2022 13.85 Mn
Mar 31, 2022 12.92 Mn
Dec 31, 2021 11.45 Mn
Sep 30, 2021 11.77 Mn